Detalhe da pesquisa
1.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Int J Gynecol Cancer
; 32(6): 753-760, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063943
2.
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
BMC Cancer
; 21(1): 1113, 2021 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663254
3.
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
BMC Cancer
; 21(1): 514, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962592
4.
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
Prostate
; 78(6): 435-445, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29431193
5.
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response.
J Transl Med
; 15(1): 150, 2017 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28662677
6.
A patient with progressive dyspnoea and a new heart murmur.
Acta Cardiol
; 69(3): 322-4, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25029882
7.
The Changing Landscape of Systemic Therapy in the Treatment of Synchronous Metastatic Hormone-sensitive Prostate Cancer.
Clin Genitourin Cancer
; 21(3): 415.e1-415.e8, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529628
8.
Radiotherapy Use in Muscle-Invasive Bladder Cancer: Review of the Guidelines and Impact of Increased Awareness in Patient Referral at a Tertiary Center in Belgium.
Cancer Manag Res
; 15: 511-521, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337479
9.
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(9): 1205-1213, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410476
10.
Targeting FGFR in bladder cancer: ready for clinical practice?
Acta Clin Belg
; 75(1): 49-56, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31671027
11.
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.
Eur Urol
; 75(5): 707-711, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665814
12.
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 25(6): 1766-1773, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30209161
13.
Pembrolizumab for the treatment of bladder cancer.
Expert Rev Anticancer Ther
; 18(2): 107-114, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29284318
14.
Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium.
Clin Genitourin Cancer
; 16(6): e1159-e1169, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190222
15.
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
Genome Med
; 10(1): 85, 2018 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458854
16.
Checkpoint inhibition: new treatment options in urologic cancer.
Acta Clin Belg
; 72(1): 24-28, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28151378
17.
Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.
Clin Nucl Med
; 42(4): e207-e209, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28134691
18.
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial.
Radiat Oncol
; 12(1): 157, 2017 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28938918
19.
Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinations.
Urol Oncol
; 33(7): 310-21, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25708954